The rising interest in GLP-1 agonists for diabetes has sparked a debate about delivery methods : skin-applied devices versus capsules. Traditionally , GLP-1 therapies were exclusively available in tablet https://alleneqls398260.blogdemls.com/40751674/glp-1-transdermal-delivery-systems-vs-pills-is-best-for-you